Sustainable growth that ensures long-term corporate success is the cornerstone of Grifols’ strategy for the future. Grounded in a solid corporate governance structure, the group aspires to turn risks into opportunities by effectively addressing core challenges – societal, environmental and climate change issues, among them – at all organizational levels. 

Grifols has pursued a strategy of long-term sustainability since its establishment. For more than 100 years, the group has been at the forefront of innovation and initiatives to enhance the ethical, technical and safety standards of plasma-derived medicines, blood transfusions and healthcare solutions.

Given the multifaceted, transversal approach that these global challenges require, “One Grifols” highlights our core values and efforts to continue our long-term sustainable future.